Koyfin Home > Directory > Health Care > Akebia Therapeutics > EV / Sales (ltm)

Akebia Therapeutics EV / Sales (ltm) Chart (AKBA)

Akebia Therapeutics annual/quarterly EV / Sales (ltm) from 2017 to 2020.
  • Akebia Therapeutics EV / Sales (ltm) for the quarter ending September 09, 2020 was 0.62 a -10.87% decrease of -0.07 year over year
  • Akebia Therapeutics EV / Sales (ltm) for the last 12 months ending September 09, 2020 was 0.62 a -10.87% decrease of -0.07 year over year
  • Akebia Therapeutics Annual EV / Sales (ltm) for 2020 was 0.62 a -2.04% decrease of -0.01 from 2019
  • Akebia Therapeutics Annual EV / Sales (ltm) for 2020 was 0.63 a 1.33% increase of 0.01 from 2019
  • Akebia Therapeutics Annual EV / Sales (ltm) for 2020 was 0.62 a -10.12% decrease of -0.06 from 2019
Other Valuation Metrics:
  • Akebia Therapeutics Market Cap for the quarter ending March 03, 2018 was $535m a -24.92% decrease of -133m year over year
  • Akebia Therapeutics Price / Book for the quarter ending March 03, 2018 was 3.80 a -378.76% decrease of -14.40 year over year
  • Akebia Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $217m a -91.84% decrease of -199m year over year
View Chart On Koyfin

Quarterly AKBA EV / Sales (ltm) Data

09/20200.62
09/20200.63
09/20200.62
09/20200.69
09/20200.57
09/20200.56
09/20200.58
09/20200.51
09/20200.54
09/20200.56

Annual AKBA EV / Sales (ltm) Data

20200.62
20200.63
20200.62
20200.69
20200.57
20200.56
20200.58
20200.51
20200.54
20200.56